Compare IBRX & EPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IBRX | EPAC |
|---|---|---|
| Founded | 2014 | 1910 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.1B |
| IPO Year | N/A | N/A |
| Metric | IBRX | EPAC |
|---|---|---|
| Price | $6.23 | $40.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $11.80 | ★ $50.50 |
| AVG Volume (30 Days) | ★ 46.1M | 435.4K |
| Earning Date | 03-02-2026 | 12-17-2025 |
| Dividend Yield | N/A | ★ 0.10% |
| EPS Growth | N/A | ★ 0.98 |
| EPS | N/A | ★ 1.66 |
| Revenue | $82,555,000.00 | ★ $615,911,000.00 |
| Revenue This Year | $680.06 | $5.17 |
| Revenue Next Year | $90.18 | $5.97 |
| P/E Ratio | ★ N/A | $24.58 |
| Revenue Growth | ★ 1025.95 | 3.91 |
| 52 Week Low | $1.83 | $35.01 |
| 52 Week High | $8.28 | $47.47 |
| Indicator | IBRX | EPAC |
|---|---|---|
| Relative Strength Index (RSI) | 75.41 | 52.32 |
| Support Level | $5.71 | $40.00 |
| Resistance Level | $8.28 | $42.43 |
| Average True Range (ATR) | 0.67 | 0.97 |
| MACD | 0.42 | 0.04 |
| Stochastic Oscillator | 67.10 | 48.81 |
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.
Enerpac Tool Group Corp provides high-precision hydraulic and mechanical tools, controlled-force products, and heavy lifting solutions. Operating mainly through its Industrial Tools & Services (IT&S) segment, the company designs, manufactures, and distributes branded tools, and offers maintenance, bolting, machining, joint integrity, and equipment rental services across industries such as oil & gas, manufacturing, power generation, and infrastructure. Its key products include hydraulic cylinders, pumps, torque wrenches, and bolt tensioners under the brands ENERPAC and HYDRATIGHT. The company serves customers internationally, with operations in the USA, Australia, Brazil, Germany, Saudi Arabia, the United Kingdom, and other countries, deriving the majority of its revenue from the USA.